GLP-1 Drugs Explained: From Ozempic to Retatrutide
Ozempic triggered a revolution by cutting injections from twice daily to once weekly. Retatrutide adds a third receptor key — GLP-1, GIP, and glucagon — delivering 28.3% body weight loss in Phase 3 trials. Think of each generation as a Pokemon evolution, and we're not close to the final form.
